These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24351172)

  • 1. In silico optimization of basal insulin infusion rate during exercise: implication for artificial pancreas.
    Schiavon M; Dalla Man C; Kudva YC; Basu A; Cobelli C
    J Diabetes Sci Technol; 2013 Nov; 7(6):1461-9. PubMed ID: 24351172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico Analysis of an Exercise-Safe Artificial Pancreas With Multistage Model Predictive Control and Insulin Safety System.
    Garcia-Tirado J; Colmegna P; Corbett JP; Ozaslan B; Breton MD
    J Diabetes Sci Technol; 2019 Nov; 13(6):1054-1064. PubMed ID: 31679400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.
    Kovatchev B; Cobelli C; Renard E; Anderson S; Breton M; Patek S; Clarke W; Bruttomesso D; Maran A; Costa S; Avogaro A; Dalla Man C; Facchinetti A; Magni L; De Nicolao G; Place J; Farret A
    J Diabetes Sci Technol; 2010 Nov; 4(6):1374-81. PubMed ID: 21129332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
    Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
    J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial pancreas: model predictive control design from clinical experience.
    Toffanin C; Messori M; Di Palma F; De Nicolao G; Cobelli C; Magni L
    J Diabetes Sci Technol; 2013 Nov; 7(6):1470-83. PubMed ID: 24351173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The university of Virginia/Padova type 1 diabetes simulator matches the glucose traces of a clinical trial.
    Visentin R; Dalla Man C; Kovatchev B; Cobelli C
    Diabetes Technol Ther; 2014 Jul; 16(7):428-34. PubMed ID: 24571584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.
    Grosman B; Dassau E; Zisser HC; Jovanovic L; Doyle FJ
    J Diabetes Sci Technol; 2010 Jul; 4(4):961-75. PubMed ID: 20663463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results.
    Toffanin C; Visentin R; Messori M; Palma FD; Magni L; Cobelli C
    IEEE Trans Biomed Eng; 2018 Mar; 65(3):479-488. PubMed ID: 28092515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automatic bolus and adaptive basal algorithm for the artificial pancreatic β-cell.
    Wang Y; Dassau E; Zisser H; Jovanovič L; Doyle FJ
    Diabetes Technol Ther; 2010 Nov; 12(11):879-87. PubMed ID: 20879966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periodic-zone model predictive control for diurnal closed-loop operation of an artificial pancreas.
    Gondhalekar R; Dassau E; Zisser HC; Doyle FJ
    J Diabetes Sci Technol; 2013 Nov; 7(6):1446-60. PubMed ID: 24351171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control to range for diabetes: functionality and modular architecture.
    Kovatchev B; Patek S; Dassau E; Doyle FJ; Magni L; De Nicolao G; Cobelli C;
    J Diabetes Sci Technol; 2009 Sep; 3(5):1058-65. PubMed ID: 20144419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining basal-bolus insulin infusion for tight postprandial glucose control: an in silico evaluation in adults, children, and adolescents.
    Revert A; Rossetti P; Calm R; Vehí J; Bondia J
    J Diabetes Sci Technol; 2010 Nov; 4(6):1424-37. PubMed ID: 21129338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive Control of an Artificial Pancreas Using Model Identification, Adaptive Postprandial Insulin Delivery, and Heart Rate and Accelerometry as Control Inputs.
    Resalat N; Hilts W; Youssef JE; Tyler N; Castle JR; Jacobs PG
    J Diabetes Sci Technol; 2019 Nov; 13(6):1044-1053. PubMed ID: 31595784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Mitigation Methods to Reduce the Risk of Hypoglycemia for Announced Exercise in a Uni-hormonal Artificial Pancreas.
    Bertachi A; Beneyto A; Ramkissoon CM; Vehí J
    Diabetes Technol Ther; 2018 Apr; 20(4):285-295. PubMed ID: 29608335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.
    Magni L; Forgione M; Toffanin C; Dalla Man C; Kovatchev B; De Nicolao G; Cobelli C
    J Diabetes Sci Technol; 2009 Sep; 3(5):1091-8. PubMed ID: 20144422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel adaptive basal therapy based on the value and rate of change of blood glucose.
    Wang Y; Percival MW; Dassau E; Zisser HC; Jovanovic L; Doyle FJ
    J Diabetes Sci Technol; 2009 Sep; 3(5):1099-108. PubMed ID: 20144423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing Glucose Variability Due to Meals and Postprandial Exercise in T1DM Using Switched LPV Control: In Silico Studies.
    Colmegna PH; Sánchez-Peña RS; Gondhalekar R; Dassau E; Doyle FJ
    J Diabetes Sci Technol; 2016 May; 10(3):744-53. PubMed ID: 27022097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic Insulin Basal Needs Estimation and Parameters Adjustment in Type 1 Diabetes.
    Berián J; Bravo I; Gardel-Vicente A; Lázaro-Galilea JL; Rigla M
    Sensors (Basel); 2021 Aug; 21(15):. PubMed ID: 34372462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemia prevention via pump attenuation and red-yellow-green "traffic" lights using continuous glucose monitoring and insulin pump data.
    Hughes CS; Patek SD; Breton MD; Kovatchev BP
    J Diabetes Sci Technol; 2010 Sep; 4(5):1146-55. PubMed ID: 20920434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.